Price T Rowe Associates Inc Viatris Inc Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Viatris Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 48,785,230 shares of VTRS stock, worth $605 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
48,785,230
Previous 56,823,030 14.15%
Holding current value
$605 Million
Previous $604 Million 6.23%
% of portfolio
0.07%
Previous 0.07%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$10.32 - $12.13 $83 Million - $97.5 Million
-8,037,800 Reduced 14.15%
48,785,230 $566 Million
Q2 2024

Aug 14, 2024
SELL
$10.05 - $12.02 $10.7 Million - $12.8 Million
-1,061,401 Reduced 1.83%
56,823,030 $604 Million
Q1 2024

May 15, 2024
BUY
$11.27 - $13.53 $94.9 Million - $114 Million
8,418,678 Added 17.02%
57,884,431 $691 Million
Q4 2023

Feb 14, 2024
SELL
$8.77 - $10.85 $6.57 Million - $8.13 Million
-749,259 Reduced 1.49%
49,465,753 $536 Million
Q3 2023

Nov 14, 2023
BUY
$9.59 - $11.35 $16.5 Million - $19.5 Million
1,715,646 Added 3.54%
50,215,012 $495 Million
Q2 2023

Aug 14, 2023
BUY
$9.02 - $10.29 $65 Million - $74.2 Million
7,208,400 Added 17.46%
48,499,366 $484 Million
Q1 2023

May 15, 2023
BUY
$9.2 - $12.26 $79.9 Million - $106 Million
8,679,972 Added 26.62%
41,290,966 $397 Million
Q4 2022

Feb 14, 2023
BUY
$8.72 - $11.56 $35.2 Million - $46.7 Million
4,036,373 Added 14.13%
32,610,994 $363 Million
Q3 2022

Nov 14, 2022
BUY
$8.48 - $11.13 $229 Million - $300 Million
26,993,280 Added 1706.99%
28,574,621 $243 Million
Q2 2022

Aug 15, 2022
SELL
$9.95 - $12.27 $1.33 Million - $1.64 Million
-133,537 Reduced 7.79%
1,581,341 $16.6 Million
Q1 2022

May 16, 2022
SELL
$9.81 - $15.4 $960,457 - $1.51 Million
-97,906 Reduced 5.4%
1,714,878 $18.7 Million
Q4 2021

Feb 14, 2022
SELL
$12.09 - $14.68 $946,284 - $1.15 Million
-78,270 Reduced 4.14%
1,812,784 $24.5 Million
Q3 2021

Nov 15, 2021
SELL
$13.25 - $15.13 $556,672 - $635,656
-42,013 Reduced 2.17%
1,891,054 $25.6 Million
Q2 2021

Aug 16, 2021
SELL
$12.97 - $16.15 $201,151 - $250,470
-15,509 Reduced 0.8%
1,933,067 $27.6 Million
Q1 2021

May 17, 2021
SELL
$13.59 - $18.54 $2.3 Million - $3.14 Million
-169,291 Reduced 7.99%
1,948,576 $27.2 Million
Q4 2020

Feb 16, 2021
BUY
$14.3 - $18.74 $30.3 Million - $39.7 Million
2,117,867 New
2,117,867 $39.7 Million

Others Institutions Holding VTRS

# of Institutions
1,102
Shares Held
933M
Call Options Held
2.71M
Put Options Held
2.4M
View Full List

About Viatris Inc

VTRS Quotes by TradingView
  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email